Literature DB >> 27009394

Radiation oncology in the era of precision medicine.

Michael Baumann1,2,3,4,5,6, Mechthild Krause1,2,3,4,5,6, Jens Overgaard7, Jürgen Debus5,8,9,10,11, Søren M Bentzen12, Juliane Daartz13, Christian Richter1,2,3,4,5, Daniel Zips5,14,15, Thomas Bortfeld13.   

Abstract

Technological advances and clinical research over the past few decades have given radiation oncologists the capability to personalize treatments for accurate delivery of radiation dose based on clinical parameters and anatomical information. Eradication of gross and microscopic tumours with preservation of health-related quality of life can be achieved in many patients. Two major strategies, acting synergistically, will enable further widening of the therapeutic window of radiation oncology in the era of precision medicine: technology-driven improvement of treatment conformity, including advanced image guidance and particle therapy, and novel biological concepts for personalized treatment, including biomarker-guided prescription, combined treatment modalities and adaptation of treatment during its course.

Entities:  

Mesh:

Year:  2016        PMID: 27009394     DOI: 10.1038/nrc.2016.18

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  218 in total

1.  Three A's of repopulation during fractionated irradiation of squamous epithelia: Asymmetry loss, Acceleration of stem-cell divisions and Abortive divisions.

Authors:  W Dörr
Journal:  Int J Radiat Biol       Date:  1997-12       Impact factor: 2.694

2.  Maximizing dosimetric benefits of IMRT in the treatment of localized prostate cancer through multicriteria optimization planning.

Authors:  Jeremiah Wala; David Craft; Jon Paly; Anthony Zietman; Jason Efstathiou
Journal:  Med Dosim       Date:  2013-03-26       Impact factor: 1.482

3.  Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck.

Authors:  M Nordsmark; M Overgaard; J Overgaard
Journal:  Radiother Oncol       Date:  1996-10       Impact factor: 6.280

4.  Early FDG PET at 10 or 20 Gy under chemoradiotherapy is prognostic for locoregional control and overall survival in patients with head and neck cancer.

Authors:  Maria Hentschel; Steffen Appold; Andreas Schreiber; Nasreddin Abolmaali; Andrij Abramyuk; Wolfgang Dörr; Joerg Kotzerke; Michael Baumann; Klaus Zöphel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-02-25       Impact factor: 9.236

5.  Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker.

Authors:  J A Raleigh; D P Calkins-Adams; L H Rinker; C A Ballenger; M C Weissler; W C Fowler; D B Novotny; M A Varia
Journal:  Cancer Res       Date:  1998-09-01       Impact factor: 12.701

6.  Relative biological effectiveness of carbon ions for local tumor control of a radioresistant prostate carcinoma in the rat.

Authors:  Peter Peschke; Christian P Karger; Michael Scholz; Jürgen Debus; Peter E Huber
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-10-08       Impact factor: 7.038

7.  Decreased repopulation as well as increased reoxygenation contribute to the improvement in local control after targeting of the EGFR by C225 during fractionated irradiation.

Authors:  Mechthild Krause; Gernot Ostermann; Cordula Petersen; Ala Yaromina; Franziska Hessel; Andreas Harstrick; Albert J van der Kogel; Howard D Thames; Michael Baumann
Journal:  Radiother Oncol       Date:  2005-08       Impact factor: 6.280

8.  A simulation framework for modeling tumor control probability in breast conserving therapy.

Authors:  Wei Chen; Kenneth Gilhuijs; Joep Stroom; Harry Bartelink; Jan-Jakob Sonke
Journal:  Radiother Oncol       Date:  2014-04-17       Impact factor: 6.280

9.  Comparative dosimetry of three-phase adaptive and non-adaptive dose-painting IMRT for head-and-neck cancer.

Authors:  Luiza A M Olteanu; Dieter Berwouts; Indira Madani; Werner De Gersem; Tom Vercauteren; Fréderic Duprez; Wilfried De Neve
Journal:  Radiother Oncol       Date:  2014-04-17       Impact factor: 6.280

10.  Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix.

Authors:  M Höckel; C Knoop; K Schlenger; B Vorndran; E Baussmann; M Mitze; P G Knapstein; P Vaupel
Journal:  Radiother Oncol       Date:  1993-01       Impact factor: 6.280

View more
  191 in total

1.  Developing Predictive or Prognostic Biomarkers for Charged Particle Radiotherapy.

Authors:  Michael D Story; Jing Wang
Journal:  Int J Part Ther       Date:  2018

Review 2.  [Radiotherapeutic management of lymphatic fistulas : An effective but disregarded therapy option].

Authors:  D Habermehl; G Habl; H-H Eckstein; F Meisner; S E Combs
Journal:  Chirurg       Date:  2017-04       Impact factor: 0.955

3.  Future directions on the merge of quantitative imaging and artificial intelligence in radiation oncology.

Authors:  Kathrine Røe Redalen; Daniela Thorwarth
Journal:  Phys Imaging Radiat Oncol       Date:  2020-07-15

4.  Radiation-induced synthetic lethality: combination of poly(ADP-ribose) polymerase and RAD51 inhibitors to sensitize cells to proton irradiation.

Authors:  Anne-Catherine Wéra; Alison Lobbens; Miroslav Stoyanov; Stéphane Lucas; Carine Michiels
Journal:  Cell Cycle       Date:  2019-06-25       Impact factor: 4.534

5.  Modeling Cellular Response in Large-Scale Radiogenomic Databases to Advance Precision Radiotherapy.

Authors:  Venkata Sk Manem; Meghan Lambie; Ian Smith; Petr Smirnov; Victor Kofia; Mark Freeman; Marianne Koritzinsky; Mohamed E Abazeed; Benjamin Haibe-Kains; Scott V Bratman
Journal:  Cancer Res       Date:  2019-09-26       Impact factor: 12.701

6.  Harnessing radiation to improve immunotherapy: better with particles?

Authors:  Marco Durante; Silvia Formenti
Journal:  Br J Radiol       Date:  2019-07-22       Impact factor: 3.039

7.  Unraveling biophysical interactions of radiation pneumonitis in non-small-cell lung cancer via Bayesian network analysis.

Authors:  Yi Luo; Issam El Naqa; Daniel L McShan; Dipankar Ray; Ines Lohse; Martha M Matuszak; Dawn Owen; Shruti Jolly; Theodore S Lawrence; Feng-Ming Spring Kong; Randall K Ten Haken
Journal:  Radiother Oncol       Date:  2017-02-22       Impact factor: 6.280

Review 8.  Use of Cyclodextrins in Anticancer Photodynamic Therapy Treatment.

Authors:  Amina Ben Mihoub; Ludivine Larue; Albert Moussaron; Zahraa Youssef; Ludovic Colombeau; Francis Baros; Céline Frochot; Régis Vanderesse; Samir Acherar
Journal:  Molecules       Date:  2018-08-02       Impact factor: 4.411

9.  Target Volume Delineation Using Diffusion-weighted Imaging for MR-guided Radiotherapy: A Case Series of Laryngeal Cancer Validated by Pathology.

Authors:  Hans Ligtenberg; Tim Schakel; Jan Willem Dankbaar; Lilian N Ruiter; Boris Peltenburg; Stefan M Willems; Nicolien Kasperts; Chris H J Terhaard; Cornelis P J Raaijmakers; Marielle E P Philippens
Journal:  Cureus       Date:  2018-04-11

10.  Radiation-Drug Combinations to Improve Clinical Outcomes and Reduce Normal Tissue Toxicities: Current Challenges and New Approaches: Report of the Symposium Held at the 63rd Annual Meeting of the Radiation Research Society, 15-18 October 2017; Cancun, Mexico.

Authors:  Kelly C Falls; Ricky A Sharma; Yaacov R Lawrence; Richard A Amos; Sunil J Advani; Mansoor M Ahmed; Bhadrasain Vikram; C Norman Coleman; Pataje G Prasanna
Journal:  Radiat Res       Date:  2018-10       Impact factor: 2.841

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.